Haisco Pharmaceutical: Alin plans to reduce its holding of the company's shares by no more than 0.97%.

Heisen Pharmaceutical announced that the company's director and general manager, Alan, plans to reduce his holdings by no more than 1.4721 million shares, accounting for 0.97% of the company's total share capital, within 3 months after 15 trading days from the disclosure of the announcement through centralized bidding or block trading. Alan currently holds 3.96% of the company's shares, and the reason for the reduction is personal financial needs. The reduction price will not be lower than the issue price of the company's initial public offering.